Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients

NCT06327594 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT06327594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06327594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2023
Completion date
November 30, 2028
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, sarcopenia, ultrasound